Purchase Order 36C26326P0149
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical device innovation, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on November 7, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota with an ultimate completion date of November 10, 2025. This award carries no set-aside designation and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order on December 8, 2025, by Veterans Integrated Service Network (VISN) 23 for TAVR (transcatheter aortic valve replacement) equipment and related products. The contract, with a ceiling value of $34,000, has an ultimate completion date of December 10, 2025, and will be performed in Minneapolis, Minnesota. No set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 for TAVR (transcatheter aortic valve replacement) products. The contract, which was not set aside for any business category, is scheduled for completion by November 17, 2025, with performance occurring in Minneapolis, Minnesota. As the sole manufacturer of the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 23 for a TAVR (transcatheter aortic valve replacement) kit prosthetics delivery on October 24, 2025. The contract, valued at $34,000, is not subject to any set-aside designation and is scheduled for completion by October 28, 2025. The award supports the Department of Veterans Affairs'...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 23 on October 17, 2025. The contract, designated as TAVR (Transcatheter Aortic Valve Replacement), will be performed in Minneapolis, Minnesota and is scheduled for completion by October 20, 2025. This award does not utilize a set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota. This award represents no set-aside designation and reflects the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of transcatheter and surgical cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on October 31, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, is not set-aside and will be performed in Minneapolis, Minnesota, with an ultimate completion date of December 30, 2025. As the sole...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for specialized transcatheter aortic valve replacement (TAVR) products. The contract, awarded on June 9, 2025, with a completion date of June 11, 2025, is for delivery to Minneapolis, Minnesota. No set-aside designation was applied to this award, and...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) equipment and related cardiovascular medical devices. The contract, issued on October 31, 2025, with performance in Minneapolis, Minnesota, represents a non-set-aside procurement of specialized heart valve technology. Edwards Lifesciences LLC, a leading manufacturer of advanced...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (VISN 23) on December 12, 2025. The contract, classified as a transcatheter aortic valve replacement (TAVR) procurement, has an ultimate completion date of December 15, 2025 and will be performed in Minneapolis, Minnesota. This award represents a non-competitive, sole-source purchase order with no set-aside designation, reflecting the specialized nature of Edwards Lifesciences' cardiovascular medical technologies and their established role as the primary supplier of advanced heart valve systems to the Department of Veterans Affairs. This purchase order aligns with Edwards Lifesciences LLC's ongoing relationship with the VA, which includes two significant indefinite delivery contracts valued at $2.5 million and $1.25 million respectively. The company's federal contracting portfolio demonstrates consistent delivery of specialized cardiac devices including SAPIEN 3 transcatheter heart valves, INSPIRIS RESILIA aortic valves, and related surgical implants. This specific TAVR procurement supports the VA's mission to provide advanced cardiovascular care to veterans, with the short timeframe between award and completion reflecting the time-sensitive nature of medical device procurement for surgical procedures.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--PROS V23 618 UNU BILL & REPLACE 255022 (MI) TAVR (NEED ON 12/16/2025) (VA-26-00030987) | 36C26326Q0212 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 | Award Notice 1/1 | 12/12/25, 11:43 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 12/12/25 |